Patterns of myocardial late enhancement: Typical and atypical features

Archives of Cardiovascular Diseases

Volumn 105, Issue 5, 2012, Pages 300-308

  Vermes, Emmanuelle ^a   Carbone, Iacopo ^a   Friedrich, Matthias G ^a   Merchant, Naeem ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Cardiomyopathy; Cardiovascular magnetic resonance; Late gadolinium enhancement

Indexed keywords

GADOLINIUM;

ACUTE HEART INFARCTION; ACUTE MYOCARDITIS; CARDIAC IMAGING; CLINICAL PRACTICE; CONGESTIVE CARDIOMYOPATHY; CONTRAST ENHANCEMENT; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MEDICAL LITERATURE; MYOCARDIAL LATE ENHANCEMENT; MYOCARDITIS; REVIEW;

ADULT; AGED, 80 AND OVER; CONTRAST MEDIA; FEMALE; GADOLINIUM; HEART DISEASES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYOCARDIUM; PREDICTIVE VALUE OF TESTS; PROGNOSIS; YOUNG ADULT;

EID: 84862838262     PISSN: 18752136     EISSN: 18752128     Source Type: Journal    
DOI: 10.1016/j.acvd.2011.12.006     Document Type: Review

References (13)

1. Rehwald WG, Fieno DS, Chen EL, et al. Myocardial magnetic resonance imaging contrast agent concentrations after reversible and irreversible ischemic injury. Circulation 2002;105:224-9.
2. Reimer KA, Jennings RB. The wavefront phenomenon of myocardial ischemic cell death. II. Transmural progression of necrosis within the framework of ischemic bed size (myocardium at risk) and collateral flow. Lab Invest 1979;40:633-44.
3. Bogaert J, Kalantzi M, Rademakers FE, et al. Determinants and impact of microvascular obstruction in successfully reperfused ST-segment elevation myocardial infarction. Assessment by magnetic resonance imaging. Eur Radiol 2007;17: 2572-80.
4. Wu KC, Zerhouni EA, Judd RM, et al. Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. Circulation 1998;97:765-72.
5. Magnani JW, Dec GW. Myocarditis: current trends in diagnosis and treatment. Circulation 2006;113:876-90.
6. Friedrich MG, Sechtem U, Schulz-Menger J, et al. Cardiovascular magnetic resonance in myocarditis: a JACC White Paper. J Am Coll Cardiol 2009;53:1475-87.
7. Korkusuz H, Esters P, Naguib N, et al. Acute myocarditis in a rat model: late gadolinium enhancement with histopathological correlation. Eur Radiol 2009;19:2672-8.
8. McCrohon JA, Moon JC, Prasad SK, et al. Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation 2003;108:54-9.
9. Strohm O, Schulz-Menger J, Pilz B, et al. Measurement of left ventricular dimensions and function in patients with dilated cardiomyopathy. J Magn Reson Imaging 2001;13:367-71.
10. Assomull RG, Prasad SK, Lyne J, et al. Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol 2006;48:1977-85.
11. Hansen MW, Merchant N. MRI of hypertrophic cardiomyopathy: part I, MRI appearances. AJR Am J Roentgenol 2007;189:1335-43.
12. Rickers C, Wilke NM, Jerosch-Herold M, et al. Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy. Circulation 2005;112:855-61.
13. O'Hanlon R, Grasso A, Roughton M, et al. Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy. J Am Coll Cardiol 2010;56:867-74.